Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan:126:108470.
doi: 10.1016/j.yebeh.2021.108470. Epub 2021 Dec 10.

Ictogenesis of viral pneumonia: A comparison between SARS-CoV-2 and H1N1/H3N2

Affiliations

Ictogenesis of viral pneumonia: A comparison between SARS-CoV-2 and H1N1/H3N2

Chiara Milano et al. Epilepsy Behav. 2022 Jan.

Abstract

Several studies reported acute symptomatic seizures as a possible neurological complication of COVID-19 pneumonia. Apart from metabolic imbalances, hypoxia, and fever, other ictogenic mechanisms are likely related to an immune-mediated damage. The same mechanisms are shared by other respiratory viruses. Since neurotropic properties of SARS-CoV-2 have been questioned, we investigated whether SARS-CoV-2 has a similar ictogenic potential to other respiratory non-neurotropic viruses. We conducted a retrospective study identifying 1141 patients with SARS-CoV-2 pneumonia and 146 patients with H1N1/H3N2 pneumonia. We found a similar prevalence of seizures in the two viral pneumonia (1.05% with SARS-CoV-2 vs 2.05% with influenza; p = 0.26). We detailed clinical, electroencephalographic, and neuroradiological features of each patient, together with the hypothesized pathogenesis of seizures. Previous epilepsy or pre-existing predisposing conditions (i.e., Alzheimer's disease, stroke, cerebral neoplasia) were found in one-third of patients that experienced seizures, while two-thirds of patients had seizures without known risk factors other than pneumonia in both groups. The prevalence of pre-existing predisposing conditions and disease severity indexes was similar in SARS-CoV-2 and H1N1/H3N2 pneumonia, thus excluding they could act as potential confounders. Considering all the patients with viral pneumonia together, previous epilepsy (p < 0.001) and the need for ventilatory support (p < 0.001), but not the presence of pre-existing predisposing conditions (p = 0.290), were associated with seizure risk. Our study showed that SARS-CoV-2 and influenza viruses share a similar ictogenic potential. In both these infections, seizures are rare but serious events, and can manifest without pre-existing predisposing conditions, in particular when pneumonia is severe, thus suggesting an interplay between disease severity and host response as a major mechanism of ictogenesis, rather than a virus-specific mechanism.

Keywords: Ictogenic potential; Influenza; Pneumonia; SARS-CoV-2; Seizures.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Study flowchart.

References

    1. Vohora D., Jain S., Tripathi M., Potschka H. COVID-19 and seizures: Is there a link? Epilepsia. 2020 doi: 10.1111/epi.16656. - DOI - PMC - PubMed
    1. Dono F., Nucera B., Lanzone J., Evangelista G., Rinaldi F., Speranza R., et al. Status epilepticus and COVID-19: a systematic review. Epilepsy Behav. 2021;118 doi: 10.1016/j.yebeh.2021.107887. - DOI - PMC - PubMed
    1. Baig A.M., Khaleeq A., Ali U., Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020 doi: 10.1021/acschemneuro.0c00122. - DOI - PubMed
    1. Solomon T. Neurological infection with SARS-CoV-2 — the story so far. Nat Rev Neurol. 2021 doi: 10.1038/s41582-020-00453-w. - DOI - PMC - PubMed
    1. Matschke J., Lütgehetmann M., Hagel C., Sperhake J.P., Schröder A.S., Edler C., et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020 doi: 10.1016/S1474-4422(20)30308-2. - DOI - PMC - PubMed